# Shinya Yamanaka

Type: Person

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/shinya-yamanaka
Canonical HTML page: https://getbiobrief.com/entity/shinya-yamanaka

## Timeline

- **2026-03-06**: Regulatory Approval — Japan grants official approval for commercial use of the therapy.
- **2024**: Trial Completion — Phase II data confirms safety and efficacy in human subjects.
- **2018**: First Human Trial — Kyoto University begins the world's first iPS cell transplant for Parkinson's.
- **2012**: Nobel Prize — Yamanaka wins the Nobel Prize in Medicine for his iPS cell research.
- **2006**: iPS Discovery — Shinya Yamanaka discovers how to create induced pluripotent stem cells.

## Recent coverage (1 stories)

### Japan Grants World-First Approval for iPS Stem-Cell Parkinson's Therapy
2026-03-06 07:54:53 · Sentiment: Strongly positive · Impact: 9/10 · Sources: 3

Japan has officially approved the world's first stem-cell-based treatment for Parkinson's disease, utilizing induced pluripotent stem (iPS) cells. The therapy, developed by Kyoto University and Sumitomo Pharma, marks a historic shift from symptom management to regenerative repair for neurodegenerative disorders.
Full story: https://getbiobrief.com/story/japan-approves-world-first-stem-cell-parkinsons-treatment

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.